Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steribite is a medical device company specializing in the development and manufacture of sterile, single-use surgical instruments for spinal and neurosurgical procedures. The company's flagship product, the Steribite Disposable Kerrison Rongeur, was FDA-cleared in 2018 to address the critical issues of infection risk and instrument dullness associated with traditional reusable rongeurs. In December 2021, Steribite merged with its long-time manufacturing partner, Precision Manufacturing Group (PMG), to bring its production entirely in-house at a state-of-the-art facility in Wooster, Ohio. This vertical integration allows the company to maintain high quality control and a robust U.S.-based supply chain. Steribite's portfolio also includes the SteriSharp limited-use rongeur and continues to expand with new disposable instruments designed to improve patient safety and surgical efficiency. By providing sharp, sterile tools for every case, the company aims to reduce operative time and enhance surgeon satisfaction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STERIBITE.